ANG Lifesciences India Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

13.06

10.37

5.18

5.18

5.18

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

72.48

73.11

36.40

29.37

23.58

Loan funds

Secured loans

52.75

60.99

39.97

18.17

18.69

Unsecured loans

-

-

-

-

-

Total

138.28

144.47

81.55

52.72

47.46

Uses of funds

Fixed assets

Gross block

107.67

103.12

37.97

33.73

32.41

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

28.99

20.80

14.11

12.79

11.65

Net block

78.68

82.32

23.86

20.94

20.76

Capital work-in-progress

-

-

0.23

0.23

-

Investments

3.52

3.52

3.52

0.02

0.02

Net current assets

Current assets, loans & advances

170.30

182.84

116.03

72.89

60.12

Less : current liabilities & provisions

114.22

124.21

62.10

41.35

33.44

Total net current assets

56.08

58.63

53.93

31.54

26.68

Miscellaneous expenses not written

-

-

-

-

-

Total

138.28

144.47

81.55

52.72

47.46

Notes:

Book value of unquoted investments

3.52

3.52

3.52

0.02

0.02

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

16.63

20.30

15.87

9.32

6.45

Number of equity sharesoutstanding (Lacs)

130.58

103.67

51.83

51.83

51.83